Skip to content

CalAmp CAMP Enterprise value

Enterprise value at other companies

Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$12.92B+175%
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
$1.77B+1,855%
Rapport Therapeutics, Inc. logo
Rapport Therapeutics, Inc.RAPP
$1.43B+352%
MeiraGTx Holdings plc logo
MeiraGTx Holdings plcMGTX
$696.49M+26.9%
Taysha Gene Therapies, Inc. logo
Taysha Gene Therapies, Inc.TSHA
$1.08B+368%
CytomX Therapeutics logo
CytomX TherapeuticsCTMX
$990.06M+8,530%

Other financials

Income statement

See full
Revenue$1.3M+50.8%
Operating income-$13.1M+0.2%
Net income-$18.3M-47.4%
EPS (diluted)-$0.32+48.4%

Balance sheet

See full
Cash & equivalents$100.8M+97.9%
Total debt$2.1M-73.2%
Total equity$30.9M-40.1%
Total assets$105.5M+68.0%

Cash flow

See full
Operating cash flow-$11.0M+23.1%
CapEx--100%
Free cash flow-$11.0M+24.6%

Valuation

See full
Market cap$226.92M+666%
P/S57.7×+47.8×

Profitability

See full
Operating margin-1,335.2%-512pp
Net margin-2,193.7%-581pp
FCF margin-1,254%

Returns & leverage

See full
Return on equity-209.3%
Debt / equity0.1×-0.1×
Current ratio6.1×-1.9×

Where this comes from

Calculated from CalAmp’s reported figures.

The official record: CalAmp’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about CalAmp's enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CalAmp's enterprise value?
CalAmp (CAMP) reported enterprise value of $130.25M in Q1 2026.
How has CalAmp's enterprise value changed year-over-year?
CalAmp's enterprise value increased by 246.3% year-over-year, from $37.61M to $130.25M.
What does enterprise value mean?
Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.